Verdicts genuinely change. Free email alert the moment MEDI's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Harbor Health Care ETF ETF · Harbor ETF Trust
44 holdings · as of 2026-07-31 (2.4 months ago)
NON-COMPLIANT 7.49% of portfolio weight is in non-compliant holdings, over the 5% threshold.
44 holdings, 33 matched (86% of weight). Portfolio as of 2026-07-31, filed 2026-09-25. Source: SEC Form N-PORT.
0.81% of this portfolio’s income is non-permissible — weighted across holdings, computed over 66% of portfolio weight (29 of 44 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
78.5% compliant 0.0% questionable 7.5% non-compliant 13.6% unscreened
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| LLY Eli Lilly & Co | COMPLIANT | 20.78% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| ASND Ascendis Pharma A/S | COMPLIANT | 13.61% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| GILD Gilead Sciences Inc | COMPLIANT | 5.10% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| RYTM Rhythm Pharmaceuticals Inc | NON_COMPLIANT | 4.02% | AAOIFI1.6% Usmani25.1% Dow Jones Islamic2.0% S&P Shariah2.5% MSCI Islamic25.1% MSCI Islamic M-Series2.5% FTSE Shariah24.3% |
| ABBV AbbVie Inc | COMPLIANT | 3.09% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| ISRG Intuitive Surgical Inc | COMPLIANT | 2.83% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| COR Cencora Inc | COMPLIANT | 2.75% | AAOIFI18.9% Usmani14.0% Dow Jones Islamic20.8% S&P Shariah22.7% MSCI Islamic14.0% MSCI Islamic M-Series22.7% FTSE Shariah14.0% |
| Revolution Medicines Inc | UNSCREENED | 2.54% | no in-house ratios for this holding |
| Insmed Inc | UNSCREENED | 2.52% | no in-house ratios for this holding |
| MRK Merck & Co Inc | COMPLIANT | 2.47% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| BSX Boston Scientific Corp | COMPLIANT | 2.40% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| NTRA Natera Inc | COMPLIANT | 2.26% | AAOIFI0.5% Usmani9.0% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic9.0% MSCI Islamic M-Series1.2% FTSE Shariah3.0% |
| Abivax SA | UNSCREENED | 2.16% | no in-house ratios for this holding |
| PODD Insulet Corp | COMPLIANT | 2.10% | AAOIFI9.6% Usmani30.0% Dow Jones Islamic5.3% S&P Shariah5.9% MSCI Islamic30.0% MSCI Islamic M-Series5.9% FTSE Shariah30.0% |
| ARGX Argenx SE | COMPLIANT | 2.07% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Vaxcyte Inc | UNSCREENED | 2.06% | no in-house ratios for this holding |
| MCK McKesson Corp | COMPLIANT | 2.02% | AAOIFI12.5% Usmani14.9% Dow Jones Islamic14.5% S&P Shariah15.8% MSCI Islamic14.7% MSCI Islamic M-Series15.8% FTSE Shariah12.5% |
| LEGN Legend Biotech Corp | COMPLIANT | 1.91% | AAOIFI8.8% Usmani18.4% Dow Jones Islamic2.9% S&P Shariah2.3% MSCI Islamic18.4% MSCI Islamic M-Series2.3% FTSE Shariah18.4% |
| DHR Danaher Corp | COMPLIANT | 1.73% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| GH Guardant Health Inc | COMPLIANT | 1.54% | AAOIFI7.8% Usmani88.7% Dow Jones Islamic17.9% S&P Shariah23.1% MSCI Islamic88.7% MSCI Islamic M-Series23.1% FTSE Shariah78.6% |
| NOVO-B.CO Novo Nordisk A/S | COMPLIANT | 1.46% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| IDXX IDEXX Laboratories Inc | COMPLIANT | 1.40% | AAOIFI1.4% Usmani16.8% Dow Jones Islamic1.3% S&P Shariah1.3% MSCI Islamic16.8% MSCI Islamic M-Series1.3% FTSE Shariah13.1% |
| UNH UnitedHealth Group Inc | NON_COMPLIANT | 1.39% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| PTCT PTC Therapeutics Inc | NON_COMPLIANT | 1.31% | AAOIFI11.9% Usmani21.4% Dow Jones Islamic16.9% S&P Shariah20.0% MSCI Islamic21.2% MSCI Islamic M-Series20.0% FTSE Shariah18.2% |
| VRTX Vertex Pharmaceuticals Inc | COMPLIANT | 1.22% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| ALNY Alnylam Pharmaceuticals Inc | COMPLIANT | 1.21% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| TMO Thermo Fisher Scientific Inc | COMPLIANT | 1.16% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| ADPT Adaptive Biotechnologies Corp | COMPLIANT | 0.98% | AAOIFI2.0% Usmani11.8% Dow Jones Islamic3.9% S&P Shariah5.1% MSCI Islamic11.8% MSCI Islamic M-Series5.1% FTSE Shariah0.0% |
| MDGL Madrigal Pharmaceuticals Inc | COMPLIANT | 0.93% | AAOIFI2.8% Usmani27.9% Dow Jones Islamic3.8% S&P Shariah4.6% MSCI Islamic27.9% MSCI Islamic M-Series4.6% FTSE Shariah27.4% |
| Praxis Precision Medicines Inc | UNSCREENED | 0.91% | no in-house ratios for this holding |
| DXCM Dexcom Inc | COMPLIANT | 0.81% | AAOIFI4.1% Usmani21.7% Dow Jones Islamic4.7% S&P Shariah4.0% MSCI Islamic20.9% MSCI Islamic M-Series4.0% FTSE Shariah19.3% |
| RadNet Inc | UNSCREENED | 0.80% | no in-house ratios for this holding |
| PEN Penumbra Inc | COMPLIANT | 0.77% | AAOIFI1.5% Usmani10.8% Dow Jones Islamic1.7% S&P Shariah1.9% MSCI Islamic9.7% MSCI Islamic M-Series1.9% FTSE Shariah0.0% |
| Relay Therapeutics Inc | UNSCREENED | 0.64% | no in-house ratios for this holding |
| Oruka Therapeutics Inc | UNSCREENED | 0.60% | no in-house ratios for this holding |
| IRTC IRhythm Holdings Inc | COMPLIANT | 0.58% | AAOIFI17.9% Usmani66.5% Dow Jones Islamic17.8% S&P Shariah19.6% MSCI Islamic66.5% MSCI Islamic M-Series19.6% FTSE Shariah59.5% |
| VTRS Viatris Inc | NON_COMPLIANT | 0.57% | AAOIFI65.8% Usmani38.9% Dow Jones Islamic100.2% S&P Shariah105.1% MSCI Islamic38.9% MSCI Islamic M-Series105.1% FTSE Shariah38.1% |
| Newamsterdam Pharma Co NV | UNSCREENED | 0.52% | no in-house ratios for this holding |
| Xenon Pharmaceuticals Inc | UNSCREENED | 0.51% | no in-house ratios for this holding |
| INDV Indivior Pharmaceuticals Inc | COMPLIANT | 0.50% | AAOIFI12.3% Usmani41.3% Dow Jones Islamic17.8% S&P Shariah18.8% MSCI Islamic41.3% MSCI Islamic M-Series18.8% FTSE Shariah39.5% |
| AXSM Axsome Therapeutics Inc | COMPLIANT | 0.49% | AAOIFI1.9% Usmani29.5% Dow Jones Islamic2.9% S&P Shariah3.5% MSCI Islamic27.6% MSCI Islamic M-Series3.5% FTSE Shariah24.7% |
| Inventiva SACA | UNSCREENED | 0.37% | no in-house ratios for this holding |
| SOPH Sophia Genetics SA | COMPLIANT | 0.33% | AAOIFI7.0% Usmani29.3% Dow Jones Islamic16.7% S&P Shariah16.9% MSCI Islamic29.3% MSCI Islamic M-Series16.9% FTSE Shariah29.3% |
| IONS Ionis Pharmaceuticals Inc | NON_COMPLIANT | 0.20% | AAOIFI21.0% Usmani67.5% Dow Jones Islamic23.0% S&P Shariah25.1% MSCI Islamic67.5% MSCI Islamic M-Series25.1% FTSE Shariah58.8% |
The published standards disagree about this fund by 53 points of portfolio weight — 64.8% of it passes AAOIFI, 12.0% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 64.8% ratios fail on 2.1% 32.7% not rated under AAOIFI
ratios pass on 20.6% ratios fail on 44.3% 34.8% not rated under Usmani
ratios pass on 58.1% ratios fail on 6.9% 34.6% not rated under Dow Jones Islamic
ratios pass on 60.2% ratios fail on 4.8% 34.6% not rated under S&P Shariah
ratios pass on 12.0% ratios fail on 55.1% 32.6% not rated under MSCI Islamic
ratios pass on 60.2% ratios fail on 4.8% 34.6% not rated under MSCI Islamic M-Series
ratios pass on 20.6% ratios fail on 44.3% 34.8% not rated under FTSE Shariah
33 of 44 listed holdings carry our own per-methodology verdicts (86% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 28 (65% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
Methodology breakdown computing — it will appear here on its own.
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
Harbor Health Care ETF (MEDI) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
Computing the full ratio and business-activity breakdown for MEDI — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 43.70 | NEUTRAL |
| Stochastic %K (14) | 57.68 | NEUTRAL |
| CCI (20) | -90.37 | NEUTRAL |
| Williams %R (14) | -42.32 | NEUTRAL |
| MACD (12,26,9) | -0.03 | SELL |
| ROC (10) | -1.03 | SELL |
| Momentum (10) | -0.34 | SELL |
| EMA (10) | 32.53 | SELL |
| SMA (10) | 32.55 | SELL |
| EMA (20) | 32.83 | SELL |
| SMA (20) | 32.82 | SELL |
| EMA (30) | 33.03 | SELL |
| SMA (30) | 33.22 | SELL |
| EMA (50) | 33.14 | SELL |
| SMA (50) | 33.56 | SELL |
| EMA (100) | 32.80 | SELL |
| SMA (100) | 32.91 | SELL |
| EMA (200) | 32.03 | BUY |
| SMA (200) | 31.78 | BUY |
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization. Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry (“health care companies”). It is non-diversified.
Background via Yahoo Finance — informational, not part of the verdict.
Average — needs more confirmation before sizing up
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 42 |
| 🕐 1H | NEUTRAL | 16 |
| ⏱ 15-Min | BEARISH | 64 |
| ⏲ 5-Min | RANGING | 194 |
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-10-06 · Asset managers net 906615 (+2612)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.